-
101
Selenium–Chondroitin Sulfate Nanoparticles Inhibit Angiogenesis by Regulating the VEGFR2-Mediated PI3K/Akt Pathway
Published 2025-01-01Subjects: “…selenium–chondroitin sulfate…”
Get full text
Article -
102
The effectiveness of chondroprotective therapy in patients with lumbosacral dorsopathies
Published 2021-06-01Subjects: Get full text
Article -
103
Experience of applying a new European chondroprotector in patients with stage 1–2 osteoarthritis in general medical practice
Published 2021-06-01Subjects: Get full text
Article -
104
Trends in the application of chondroitinase ABC in injured spinal cord repair
Published 2026-04-01Subjects: Get full text
Article -
105
DMOADs and DMARDs in the treatment of patients with joint and spine diseases
Published 2024-02-01Subjects: Get full text
Article -
106
Consistent use injectable and oral chondroprotectors in patients with osteoarthritis and lower back pain. Case report
Published 2024-12-01Subjects: Get full text
Article -
107
Hand osteoarthritis: pathogenesis, diagnosis, and approaches to therapy
Published 2019-10-01Subjects: Get full text
Article -
108
Effectiveness of the use of bioactive concentrate of marine fish in patients with back pain
Published 2024-06-01Subjects: Get full text
Article -
109
Pilot Study of Cystochon® (Cranberry Extract, Chondroitin Sulfate, and Hyaluronic Acid Complex) in Interstitial Cystitis/Bladder Pain Syndrome
Published 2022-08-01Subjects: Get full text
Article -
110
Treatment algorithm for chronic vertebrogenic back pain: the role of chondroprotectors
Published 2023-10-01Subjects: Get full text
Article -
111
Stromal modifying CHST15 siRNA enhances antitumor effect synergistically with anti-PD-1 immune checkpoint antibody in murine pancreatic cancer
Published 2025-07-01Subjects: Get full text
Article